CN101730530B - 他喷他多的滴定 - Google Patents

他喷他多的滴定 Download PDF

Info

Publication number
CN101730530B
CN101730530B CN200880021172XA CN200880021172A CN101730530B CN 101730530 B CN101730530 B CN 101730530B CN 200880021172X A CN200880021172X A CN 200880021172XA CN 200880021172 A CN200880021172 A CN 200880021172A CN 101730530 B CN101730530 B CN 101730530B
Authority
CN
China
Prior art keywords
dose
dosage
dosing
administration
tapentadol hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN200880021172XA
Other languages
English (en)
Chinese (zh)
Other versions
CN101730530A (zh
Inventor
C·兰格
F·罗姆鲍特
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN101730530(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of CN101730530A publication Critical patent/CN101730530A/zh
Application granted granted Critical
Publication of CN101730530B publication Critical patent/CN101730530B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN200880021172XA 2007-04-23 2008-04-21 他喷他多的滴定 Expired - Fee Related CN101730530B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP070082185 2007-04-23
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol
EP07008218.5 2007-04-23
PCT/EP2008/003178 WO2008128740A1 (en) 2007-04-23 2008-04-21 Titration of tapentadol

Publications (2)

Publication Number Publication Date
CN101730530A CN101730530A (zh) 2010-06-09
CN101730530B true CN101730530B (zh) 2013-10-23

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200880021172XA Expired - Fee Related CN101730530B (zh) 2007-04-23 2008-04-21 他喷他多的滴定

Country Status (21)

Country Link
US (4) US20090012180A1 (https=)
EP (5) EP1985292A1 (https=)
JP (4) JP5933176B2 (https=)
KR (3) KR20100017267A (https=)
CN (1) CN101730530B (https=)
AT (1) ATE534378T1 (https=)
AU (1) AU2008241013B2 (https=)
CA (1) CA2683786C (https=)
CY (1) CY1112320T1 (https=)
DK (1) DK2148670T3 (https=)
ES (1) ES2378255T3 (https=)
HR (1) HRP20120147T1 (https=)
IL (1) IL201479A (https=)
MX (1) MX2009011444A (https=)
NZ (1) NZ580415A (https=)
PL (1) PL2148670T3 (https=)
PT (1) PT2148670E (https=)
RU (1) RU2472497C2 (https=)
SI (1) SI2148670T1 (https=)
WO (1) WO2008128740A1 (https=)
ZA (1) ZA200907355B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
BRPI0921725A2 (pt) * 2008-10-30 2016-01-05 Grüenthal GmbH formas de dosagem potentes do tapentadol
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2566461A2 (de) * 2010-05-05 2013-03-13 Ratiopharm GmbH Festes tapentadol in nicht-kristalliner form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
PL2588093T3 (pl) * 2010-06-30 2017-07-31 Grünenthal GmbH Tapentadol do zastosowania w leczeniu zespołu jelita drażliwego
EP3597628A1 (en) * 2010-07-23 2020-01-22 Grünenthal GmbH Salts or co-crystals of 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)-phenol
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
CA2828635C (en) * 2011-03-04 2020-01-14 Grunenthal Gmbh Parenteral administration of tapentadol
KR101946790B1 (ko) 2011-03-04 2019-02-13 그뤼넨탈 게엠베하 경구 투여를 위한 타펜타돌의 수성 약제학적 제형
RS56692B1 (sr) 2011-03-04 2018-03-30 Gruenenthal Gmbh Polučvrsta vodena farmaceutska kompozicija koja sadrži tapentadol
US20120309840A1 (en) * 2011-04-05 2012-12-06 Gruenenthal Gmbh Treatment of Pain Associated with Trigeminal Neuralgia
RS58064B1 (sr) 2011-04-05 2019-02-28 Gruenenthal Gmbh Tapentadol za sprečavanje hronifikacije bola
LT3272343T (lt) 2011-04-29 2020-05-11 Grünenthal GmbH Tapentadolis, skirtas depresijos ir nerimo prevencijai ir gydymui
ES2681952T3 (es) * 2013-03-15 2018-09-17 SpecGx LLC Forma farmacéutica sólida disuasoria del abuso de liberación inmediata con puntaje funcional
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
EP3273953B1 (en) 2015-03-27 2019-01-02 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
ES2869981T3 (es) * 2015-05-26 2021-10-26 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Composiciones para su uso en el tratamiento de la enfermedad de parkinson y trastornos relacionados
JP7373904B2 (ja) * 2016-02-29 2023-11-06 パーク・セラピューティクス・インコーポレイテッド セブラノパドールの滴定
CN109996533A (zh) 2016-09-23 2019-07-09 格吕伦塔尔有限公司 用于肠胃外施用他喷他多的稳定制剂
ES3010208T3 (en) 2020-03-16 2025-04-01 Gruenenthal Gmbh Scored tablet comprising tapentadol
WO2022194941A1 (en) * 2021-03-17 2022-09-22 Actelion Pharmaceuticals Ltd Pharmaceutical dosage system
WO2022234076A1 (en) * 2021-05-07 2022-11-10 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) * 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
AU2003297073A1 (en) 2002-12-13 2004-07-09 Euro-Celtique S.A. Transdermal buprenorphine dosage regimen for analgesia
US7413749B2 (en) 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
DE102007019417A1 (de) * 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose

Also Published As

Publication number Publication date
CY1112320T1 (el) 2015-12-09
ZA200907355B (en) 2010-08-25
IL201479A (en) 2016-04-21
EP3143993A1 (en) 2017-03-22
IL201479A0 (en) 2010-05-31
WO2008128740A1 (en) 2008-10-30
PT2148670E (pt) 2012-01-24
JP2016128468A (ja) 2016-07-14
JP2018030864A (ja) 2018-03-01
EP2148670A1 (en) 2010-02-03
AU2008241013A1 (en) 2008-10-30
DK2148670T3 (da) 2012-03-12
ATE534378T1 (de) 2011-12-15
EP2422778A1 (en) 2012-02-29
US20090012180A1 (en) 2009-01-08
WO2008128740A8 (en) 2010-06-17
US11344512B2 (en) 2022-05-31
KR20100017267A (ko) 2010-02-16
KR20150027840A (ko) 2015-03-12
HK1140940A1 (en) 2010-10-29
CN101730530A (zh) 2010-06-09
SI2148670T1 (sl) 2012-03-30
NZ580415A (en) 2012-04-27
PL2148670T3 (pl) 2012-04-30
US20170079938A1 (en) 2017-03-23
AU2008241013B2 (en) 2013-06-20
KR102078999B1 (ko) 2020-02-19
JP2010531296A (ja) 2010-09-24
EP3603630A1 (en) 2020-02-05
US20160074342A1 (en) 2016-03-17
EP2148670B1 (en) 2011-11-23
KR20180004839A (ko) 2018-01-12
JP5933176B2 (ja) 2016-06-08
ES2378255T3 (es) 2012-04-10
CA2683786A1 (en) 2008-10-30
JP2019131598A (ja) 2019-08-08
RU2009142940A (ru) 2011-05-27
EP1985292A1 (en) 2008-10-29
US20190290603A1 (en) 2019-09-26
HRP20120147T1 (hr) 2012-03-31
CA2683786C (en) 2021-10-26
RU2472497C2 (ru) 2013-01-20
MX2009011444A (es) 2009-11-05

Similar Documents

Publication Publication Date Title
CN101730530B (zh) 他喷他多的滴定
US20200061003A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
US20090269402A1 (en) Modified release composition of at least one form of venlafaxine
WO2011112161A1 (en) Extended release thiocolchicoside tablets
US20100331424A1 (en) Use of Axomadol for Treatment of Arthrosis Pain
HK1233916A1 (en) Titration of tapentadol
WO2005067909A1 (en) Combination therapy with mecamylamine for the treatment of mood disorders
HK1140940B (en) Titration of tapentadol
UA77795U (uk) Застосування композиції як протиалергійного засобу
UA77796U (uk) Композиція для лікування алергічних станів
CN101180039A (zh) 至少一种形式的文拉法辛的缓释组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20131023

CF01 Termination of patent right due to non-payment of annual fee